• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于二次谐波产生技术鉴定无活性的构象选择性白细胞介素-2诱导型T细胞激酶(ITK)抑制剂

Identification of inactive conformation-selective interleukin-2-inducible T-cell kinase (ITK) inhibitors based on second-harmonic generation.

作者信息

Hantani Yoshiji, Iio Kiyosei, Hantani Rie, Umetani Kayo, Sato Toshihiro, Young Tracy, Connell Katelyn, Kintz Sam, Salafsky Joshua

机构信息

Biological/Pharmacological Research Laboratories Central Pharmaceutical Research Institute Japan Tobacco Inc. Takatsuki Osaka Japan.

Chemistry Research Laboratories Central Pharmaceutical Research Institute Japan Tobacco Inc. Takatsuki Osaka Japan.

出版信息

FEBS Open Bio. 2018 Jul 30;8(9):1412-1423. doi: 10.1002/2211-5463.12489. eCollection 2018 Sep.

DOI:10.1002/2211-5463.12489
PMID:30186743
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6120236/
Abstract

Many clinically approved protein kinase inhibitors stabilize an inactive conformation of their kinase target. Such inhibitors are generally highly selective compared to active conformation inhibitors, and consequently, general methods to identify inhibitors that stabilize an inactive conformation are much sought after. Here, we have applied a high-throughput, second-harmonic generation (SHG)-based conformational approach to identify small molecule stabilizers of the inactive conformation of interleukin-2-inducible T-cell kinase (ITK). A single-site cysteine mutant of the ITK kinase domain was created, labeled with an SHG-active dye, and tethered to a supported lipid bilayer membrane. Fourteen tool compounds, including stabilizers of the inactive and active conformations as well as nonbinders, were first examined for their effect on the conformation of the labeled ITK protein in the SHG assay. As a result, inactive conformation inhibitors were clearly distinguished from active conformation inhibitors by the intensity of SHG signal. Utilizing the SHG assay developed with the tool compounds described above, we identified the mechanism of action of 22 highly selective, inactive conformation inhibitors within a group of 105 small molecule inhibitors previously identified in a high-throughput biochemical screen. We describe here the first use of SHG for identifying and classifying inhibitors that stabilize an inactive vs. an active conformation of a protein kinase, without the need to determine costructures by X-ray crystallography. Our results suggest broad applicability to other proteins, particularly with single-site labels reporting on specific protein movements associated with selectivity.

摘要

许多临床批准的蛋白激酶抑制剂可稳定其激酶靶点的非活性构象。与活性构象抑制剂相比,此类抑制剂通常具有高度选择性,因此,人们一直在寻找鉴定稳定非活性构象抑制剂的通用方法。在此,我们应用了一种基于高通量二次谐波产生(SHG)的构象方法来鉴定白细胞介素-2诱导型T细胞激酶(ITK)非活性构象的小分子稳定剂。构建了ITK激酶结构域的单点半胱氨酸突变体,用SHG活性染料标记,并连接到支持的脂质双分子层膜上。首先在SHG分析中检测了14种工具化合物,包括非活性和活性构象的稳定剂以及非结合剂,以考察它们对标记的ITK蛋白构象的影响。结果,通过SHG信号强度可清楚地区分非活性构象抑制剂和活性构象抑制剂。利用上述工具化合物开发的SHG分析方法,我们在先前高通量生化筛选中鉴定出的105种小分子抑制剂中,确定了22种高选择性非活性构象抑制剂的作用机制。我们在此描述了首次使用SHG来鉴定和分类稳定蛋白激酶非活性与活性构象的抑制剂,而无需通过X射线晶体学确定共结构。我们的结果表明该方法对其他蛋白质具有广泛适用性,特别是对于通过单点标记报告与选择性相关的特定蛋白质运动的情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/6120236/236e3261ee35/FEB4-8-1412-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/6120236/df80ff2bcaaa/FEB4-8-1412-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/6120236/d808ef0720be/FEB4-8-1412-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/6120236/6c20c124ff4b/FEB4-8-1412-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/6120236/f1d2254c1e81/FEB4-8-1412-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/6120236/9d33d1d39d52/FEB4-8-1412-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/6120236/20d0ea504386/FEB4-8-1412-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/6120236/5b1c2c642852/FEB4-8-1412-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/6120236/2b1f93695385/FEB4-8-1412-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/6120236/92d682ce6d0c/FEB4-8-1412-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/6120236/4594a260db6b/FEB4-8-1412-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/6120236/236e3261ee35/FEB4-8-1412-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/6120236/df80ff2bcaaa/FEB4-8-1412-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/6120236/d808ef0720be/FEB4-8-1412-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/6120236/6c20c124ff4b/FEB4-8-1412-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/6120236/f1d2254c1e81/FEB4-8-1412-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/6120236/9d33d1d39d52/FEB4-8-1412-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/6120236/20d0ea504386/FEB4-8-1412-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/6120236/5b1c2c642852/FEB4-8-1412-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/6120236/2b1f93695385/FEB4-8-1412-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/6120236/92d682ce6d0c/FEB4-8-1412-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/6120236/4594a260db6b/FEB4-8-1412-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a986/6120236/236e3261ee35/FEB4-8-1412-g011.jpg

相似文献

1
Identification of inactive conformation-selective interleukin-2-inducible T-cell kinase (ITK) inhibitors based on second-harmonic generation.基于二次谐波产生技术鉴定无活性的构象选择性白细胞介素-2诱导型T细胞激酶(ITK)抑制剂
FEBS Open Bio. 2018 Jul 30;8(9):1412-1423. doi: 10.1002/2211-5463.12489. eCollection 2018 Sep.
2
Identification of a New Inhibitor That Stabilizes Interleukin-2-Inducible T-Cell Kinase in Its Inactive Conformation.鉴定一种新的抑制剂,该抑制剂能使白细胞介素 2 诱导的 T 细胞激酶稳定于非活性构象。
SLAS Discov. 2019 Sep;24(8):854-862. doi: 10.1177/2472555219857542. Epub 2019 Jun 27.
3
Conformational Selectivity of ITK Inhibitors: Insights from Molecular Dynamics Simulations.ITK 抑制剂的构象选择性:分子动力学模拟的见解。
J Chem Inf Model. 2023 Dec 25;63(24):7860-7872. doi: 10.1021/acs.jcim.3c01352. Epub 2023 Dec 9.
4
Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitors.通过别构抑制剂选择性靶向白细胞介素-2 诱导的 T 细胞激酶的无活性构象。
Biochem J. 2014 Jun 1;460(2):211-22. doi: 10.1042/BJ20131139.
5
Discovery of Inactive Conformation-Selective Kinase Inhibitors by Utilizing Cascade Assays.利用级联分析发现无活性构象选择性激酶抑制剂
Biochemistry. 2017 Aug 29;56(34):4449-4456. doi: 10.1021/acs.biochem.7b00521. Epub 2017 Jun 14.
6
High-throughput screening to identify inhibitors which stabilize inactive kinase conformations in p38alpha.高通量筛选鉴定 p38α 中稳定无活性激酶构象的抑制剂。
J Am Chem Soc. 2009 Dec 30;131(51):18478-88. doi: 10.1021/ja907795q.
7
FLiK: a direct-binding assay for the identification and kinetic characterization of stabilizers of inactive kinase conformations.FLiK:一种用于鉴定无活性激酶构象稳定剂并对其进行动力学表征的直接结合测定法。
Methods Enzymol. 2014;548:147-71. doi: 10.1016/B978-0-12-397918-6.00006-9.
8
Displacement assay for the detection of stabilizers of inactive kinase conformations.无活性激酶构象稳定剂检测的置换分析。
J Med Chem. 2010 Jan 14;53(1):357-67. doi: 10.1021/jm901297e.
9
A Role for Hydration in Interleukin-2 Inducible T Cell Kinase (Itk) Selectivity.水合作用在白细胞介素-2 诱导的 T 细胞激酶(Itk)选择性中的作用。
Mol Inform. 2011 Dec;30(11-12):950-9. doi: 10.1002/minf.201100086. Epub 2011 Nov 30.
10
Biosensor-based approach to the identification of protein kinase ligands with dual-site modes of action.基于生物传感器的方法用于鉴定具有双位点作用模式的蛋白激酶配体。
J Biomol Screen. 2012 Feb;17(2):183-93. doi: 10.1177/1087057111422746. Epub 2011 Nov 7.

引用本文的文献

1
Conformational Selectivity of ITK Inhibitors: Insights from Molecular Dynamics Simulations.ITK 抑制剂的构象选择性:分子动力学模拟的见解。
J Chem Inf Model. 2023 Dec 25;63(24):7860-7872. doi: 10.1021/acs.jcim.3c01352. Epub 2023 Dec 9.

本文引用的文献

1
Detection of Ligand-Induced Conformational Changes in Oligonucleotides by Second-Harmonic Generation at a Supported Lipid Bilayer Interface.通过在支撑脂质双层界面上的二次谐波产生检测寡核苷酸中的配体诱导构象变化。
Anal Chem. 2016 Nov 1;88(21):10482-10489. doi: 10.1021/acs.analchem.6b02498. Epub 2016 Oct 12.
2
Small Molecules Detected by Second-Harmonic Generation Modulate the Conformation of Monomeric α-Synuclein and Reduce Its Aggregation in Cells.通过二次谐波产生检测到的小分子调节单体α-突触核蛋白的构象并减少其在细胞中的聚集。
J Biol Chem. 2015 Nov 13;290(46):27582-93. doi: 10.1074/jbc.M114.636027. Epub 2015 Sep 22.
3
Protein Conformational Changes Are Detected and Resolved Site Specifically by Second-Harmonic Generation.
通过二次谐波产生可特异性地检测和分辨蛋白质构象变化。
Biophys J. 2015 Aug 18;109(4):806-15. doi: 10.1016/j.bpj.2015.07.016.
4
Conformational analysis of the DFG-out kinase motif and biochemical profiling of structurally validated type II inhibitors.DFG-out激酶基序的构象分析及结构验证的II型抑制剂的生化分析
J Med Chem. 2015 Jan 8;58(1):466-79. doi: 10.1021/jm501603h. Epub 2014 Dec 12.
5
Property- and structure-guided discovery of a tetrahydroindazole series of interleukin-2 inducible T-cell kinase inhibitors.基于结构和性质的研究发现了一系列四氢吲唑类白细胞介素-2 诱导的 T 细胞激酶抑制剂。
J Med Chem. 2014 Jul 10;57(13):5714-27. doi: 10.1021/jm500550e. Epub 2014 Jun 27.
6
Identification of a Novel and Selective Series of Itk Inhibitors via a Template-Hopping Strategy.通过模板跳跃策略鉴定新型且具有选择性的一系列Itk抑制剂。
ACS Med Chem Lett. 2013 Aug 12;4(10):948-52. doi: 10.1021/ml400206q. eCollection 2013 Oct 10.
7
Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitors.通过别构抑制剂选择性靶向白细胞介素-2 诱导的 T 细胞激酶的无活性构象。
Biochem J. 2014 Jun 1;460(2):211-22. doi: 10.1042/BJ20131139.
8
Structure-based design and synthesis of potent benzothiazole inhibitors of interleukin-2 inducible T cell kinase (ITK).基于结构的设计和合成强效苯并噻唑类白细胞介素 2 诱导的 T 细胞激酶(ITK)抑制剂。
Bioorg Med Chem Lett. 2013 Dec 1;23(23):6331-5. doi: 10.1016/j.bmcl.2013.09.069. Epub 2013 Oct 1.
9
Covalent inhibitors of interleukin-2 inducible T cell kinase (itk) with nanomolar potency in a whole-blood assay.在全血测定中具有纳摩尔效力的白细胞介素-2 诱导的 T 细胞激酶 (itk) 的共价抑制剂。
J Med Chem. 2012 Nov 26;55(22):10047-63. doi: 10.1021/jm301190s. Epub 2012 Nov 12.
10
Inhibitors of interleukin-2 inducible T-cell kinase as potential therapeutic candidates for the treatment of various inflammatory disease conditions.白细胞介素-2 诱导的 T 细胞激酶抑制剂作为治疗各种炎症性疾病的潜在治疗候选药物。
Eur J Pharm Sci. 2012 Oct 9;47(3):574-88. doi: 10.1016/j.ejps.2012.07.013. Epub 2012 Jul 20.